Female testosterone level

Kraft, S. (.). Signs of high testosterone in women. Retrieved from  http:///content/article/signs-high-testosterone-women

Low testosterone. (2012, March). Retrieved from  http:///diseases-and-conditions/mens-health/low-testosterone

Nigro, N. & Christ-Cain, M. (2012). Testosterone treatment in the aging male: Myth or reality? Swiss Medicine Weekly, 2012(142), w13539. Retrieved from  http:///content/smw-2012-13539/

NIH-supported trials of testosterone therapy in older men report mixed results. (2017, February 21). Retrieved from  https:///news-events/news-releases/nih-supported-trials-testosterone-therapy-older-men-report-mixed-results

Sharma, R., Oni, O. A., Gupta, K., Chen, G., Sharma, M., Dawn, B., … & Barua, R. S. (2015, August 6). Normalization of testosterone level is associated with reduced incidence of myocardial infarction. European Heart Journal, 36(40), 2706-2715. Retrieved from  https:///eurheartj/article/36/40/2706/2293361/Normalization-of-testosterone-level-is-associated

Sinicki, A. (.). What are prohormones? Are they safe? Retrieved from http:///entry/17328/1/What-Are-Prohormones-And-Are-They-

Testosterone and androgens. (2014, January). Retrieved from  http:///hormones-and-health/hormones/testosterone

Tsujimura, A. (2013, August 31). The relationship between testosterone deficiency and men's health.  The World Journal of Men's Health, 31 (2), 126-135. Retrieved from  http:///pmc/articles/PMC3770847/

Walker, W. H. (2010, May 27). Non-classical actions of testosterone and spermatogenesis.  Philosophical Transactions of the Royal Society of London Series B, 365 (1546). Retrieved from  http:///pmc/articles/PMC2871922/

Wein, H. (2013, September 23). Understanding how testosterone affects men. Retrieved from  https:///news-events/nih-research-matters/understanding-how-testosterone-affects-men

What is low testosterone (hypogonadism)? (.). Retrieved from  https:///urologic-conditions/low-testosterone-(hypogonadism)

Wong, J. Y. Y., Gold, E. B., Johnson, W. O., & Lee, J. S. (2015, October 2015). Circulating sex hormones and risk of uterine fibroids: Study of women's health across the nation (SWAN).  The Journal of Clinical Endocrinology & Metabolism, 101 (1), 123-130. Retrieved from  http:///doi//-2935

Ziegenfuss, T. N., Berardi, J. M., & Lowery, L. M. (2002, December). Effects of prohormone supplementation in humans: A review [Abstract]. Canadian Journal of Applied Physiology, 27 (6), 628-646. Retrieved from https:///pubmed/12501001

While the authors are justified in arguing that they found five significant results, some of their other claims are harder to defend. Smith points out that there’s a difference between a statistically significant result and a practically significant result. Two runners can have different times without one having a significant competitive advantage over the other. And while most in the track and field community would consider the two-second difference found between low-T 800 meter runners and high-T 800 meter runners to be significant, that’s only the authors’ best guess for the time difference—it could be a difference as small as a fraction of a second, or as large as four or five seconds. As Smith says, “the broader implications are unclear.”

The partition coefficient of the ester in question is important because is effects how long the drug itself stays in the system. If the testosterone transfers too quickly from the oil to the blood, the result is a sudden spike in testosterone which then rapidly drops once the dose has been used up. In the example of free testosterone injected into the muscle from a water suspension (as in Aquiviron, mentioned above), the testosterone is essentially immediately available to the bloodstream due to its low partition coefficient, and thus there is an immediate spike of testosterone which is used up quickly in the body.

Female testosterone level

female testosterone level


female testosterone levelfemale testosterone levelfemale testosterone levelfemale testosterone levelfemale testosterone level